Platform Technology Partners Raises Position in Zoetis Inc. (NYSE:ZTS)

Platform Technology Partners lifted its stake in shares of Zoetis Inc. (NYSE:ZTS) by 8.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,363 shares of the company’s stock after buying an additional 178 shares during the period. Platform Technology Partners’ holdings in Zoetis were worth $385,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. Cherry Creek Investment Advisors Inc. grew its stake in shares of Zoetis by 2.0% in the 3rd quarter. Cherry Creek Investment Advisors Inc. now owns 3,021 shares of the company’s stock worth $590,000 after acquiring an additional 58 shares in the last quarter. Grove Bank & Trust grew its position in Zoetis by 0.5% in the 3rd quarter. Grove Bank & Trust now owns 11,763 shares of the company’s stock worth $2,298,000 after purchasing an additional 61 shares in the last quarter. Hancock Whitney Corp increased its stake in Zoetis by 0.3% in the 3rd quarter. Hancock Whitney Corp now owns 18,569 shares of the company’s stock valued at $3,628,000 after buying an additional 61 shares during the last quarter. Strategy Asset Managers LLC lifted its position in shares of Zoetis by 3.5% during the 3rd quarter. Strategy Asset Managers LLC now owns 1,822 shares of the company’s stock worth $356,000 after buying an additional 62 shares in the last quarter. Finally, Procyon Advisors LLC boosted its stake in shares of Zoetis by 1.4% in the 4th quarter. Procyon Advisors LLC now owns 4,712 shares of the company’s stock worth $768,000 after buying an additional 63 shares during the last quarter. Institutional investors own 92.80% of the company’s stock.

Zoetis Trading Down 1.6 %

Shares of ZTS stock opened at $171.37 on Friday. The stock has a market capitalization of $77.32 billion, a price-to-earnings ratio of 32.21, a PEG ratio of 2.77 and a beta of 0.90. The company’s fifty day simple moving average is $169.34 and its two-hundred day simple moving average is $179.28. Zoetis Inc. has a 1 year low of $144.80 and a 1 year high of $200.53. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.69 and a quick ratio of 2.27.

Zoetis Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 3rd. Shareholders of record on Monday, April 21st will be paid a $0.50 dividend. The ex-dividend date is Monday, April 21st. This represents a $2.00 annualized dividend and a yield of 1.17%. Zoetis’s dividend payout ratio is currently 37.59%.

Analysts Set New Price Targets

ZTS has been the subject of a number of research analyst reports. Morgan Stanley decreased their price target on Zoetis from $248.00 to $243.00 and set an “overweight” rating for the company in a research report on Wednesday, January 29th. UBS Group started coverage on Zoetis in a research report on Monday, December 9th. They set a “neutral” rating and a $196.00 target price for the company. Stifel Nicolaus cut their price target on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating on the stock in a report on Tuesday, January 7th. Leerink Partnrs upgraded shares of Zoetis to a “strong-buy” rating in a report on Monday, December 2nd. Finally, JPMorgan Chase & Co. boosted their target price on shares of Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. One research analyst has rated the stock with a hold rating, ten have issued a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $215.00.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.